{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/631854a6d61d970013cd4cdc/631854a9e0c6370012ee9a44?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Disease-free survival: A controversial end point?","description":"<div>The pros and cons of using proxy measures in clinical trials. </div>","author_name":"The Medical Republic"}